Anti Viral

Anti Viral - most related articles:

- Genetic breakthrough boosting natural immunity - 4.1
- Herpes zoster or shingles risk more with rheumatoid arthritis medicines - 4
- Bone marrow can harbor HIV infected cells - 3.9
- New test to detect and identify 12 respiratory viruses - 3.7
- Drugs for epilepsy increases fracture risk in older - 2.9
- HIV progresses faster in women than in men - 2.8
- Oral steroids ineffective in preschool children's wheezing - 2.8
- Herpes virus link to complications in pregnancy - 2.7
- Small tumor protein oncoprotein identified in Merkel cell carcinoma - 2.7
- New strategies work to put cancer on the firing line - 2.6

Anti Viral articles

Cholesterol lowering drugs statins may help hospitalized influenza patients
The two main ways to prevent and control influenza today are annual immunization and antiviral drugs. A team of investigators has found that statins, cholesterol-lowering drugs, may offer an additional treatment to complement these approaches and reduce mortality among patients hospitalized with influenza.

Many US people do not know they have HIV
An estimated 1.2 million people are living with HIV in the United States. Of those, as many as 1 in 5 people (about 240,000) don't know they have HIV.

HIV infections and AIDS related cases reduced
New HIV infections and AIDS-related deaths have fallen to the lowest levels since the peak of the epidemic. New HIV infections were reduced by 21% since 1997, and deaths from AIDS-related illnesses decreased by 21% since 2005.

HIV and AIDS cases increasing among young black gay men in US
While blacks represent 14 percent of the U.S. population, they accounted for 44 percent of new HIV infections in 2009. HIV infection rates among blacks were nearly eight times higher than rates in whites.

Marked reduction of HIV among circumcised adult men
Researchers presenting late breaking research on the final day of the 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2011) have focussed on new studies in the field of circumcision, pre-exposure prophylaxis (PrEP) and antiretroviral treatment. The IAS 2011 conference has been attended by over 5000 researchers, clinicians and community leaders since Sunday in Rome.

New drug development program for children with HIV AIDS
The Drugs for Neglected Diseases initiative (DNDi) announced the launch of a new drug development programme to address critical unmet treatment needs of children with HIV/AIDS. Because HIV transmission in young children has largely been eliminated in high-income countries due to effective prevention of mother-to-child transmission (PMTCT) interventions, little market incentive exists for pharmaceutical companies to develop antiretroviral (ARV) drugs adapted for children.

HIV drugs may cause premature aging
Researchers revealed that a class of anti-retroviral drugs (NRTIs) commonly used to treat HIV can cause premature ageing, as the drugs damage DNA in the patient's mitochondria. HIV-infected people treated with antiretroviral drugs sometimes show advanced signs of frailty and age-associated diseases such as cardiovascular disease and dementia at an early age.

HAART found effective for treating HIV infected children
This observational cohort study, by Andrew Edmonds and colleagues, reports that treatment with highly active antiretroviral therapy (HAART) markedly improves the survival of HIV-infected children in Kinshasa, DRC, a resource-deprived setting. The findings presented suggest that HAART is as effective for improving the survival of HIV-infected children in a severely resource-deprived country (still recovering from civil war) as in more resource-privileged settings.

Developing possibility of a preventive vaccine against HIV AIDS
The HIV epidemic is the largest in the world and represents one of the most serious public health problems, according to data from the World Health Organization (WHO). Only 30% of the more than 10 million patients in need have the access to the antiretroviral treatment.

Antiretrovirals significantly reduces HIV transmission to partners
Men and women infected with HIV reduced the risk of transmitting the virus to their sexual partners by taking oral antiretroviral medicines when their immune systems were relatively healthy, according to findings from a large-scale clinical study.

HIV infection may be a risk factor for heart failure
Patients with HIV infection without a prior history of coronary heart disease may be at a higher risk of developing heart failure, according to a report in the Archives of Internal Medicine.

Fighting HIV in South Africa should focus on couples
HIV-positive people in South Africa take almost as much risk in their behavior when they know their partner is HIV-negative or don't know their status, as when they know their partner is already infected.

HIV virus hides in the brain
Studies of the spinal fluid of patients given anti-HIV drugs have resulted in new findings suggesting that the brain can act as a hiding place for the HIV virus.

New research to drive novel ways of treating and preventing HIV
The unwillingness of the global AIDS community to accept the status quo is fuelling a new era of scientific innovation to drive novel ways of treating and preventing HIV, organizers of the XVIII International AIDS Conference (AIDS 2010) taking place in Vienna, Austria said today.

Bone marrow can harbor HIV infected cells
University of Michigan scientists have identified a new reservoir for hidden HIV-infected cells that can serve as a factory for new infections. This indicate a new target for curing the disease so those infected with the virus may someday no longer rely on AIDS drugs for a lifetime.

Asthma complicates H1N1 in children
Asthma is a significant risk factor for severe disease in children with pandemic H1N1 compared with the seasonal flu, revealed by Canadian researchers.

Special polio vaccine drive on children's day, India
The Indian Minister of Health and Family Welfare Shri Ghulam Nabi Azad said that the Indian Government will very soon introduce bi-valent oral polio vaccine to attack the type 1 and type 3 virus to deal with the fresh outbreak of type 3 virus.

Swine flu cases decreasing in UK
The weekly number of new swine flu or Influenza A H1N1 cases in the UK continues to fall, the Chief Medical Officer said in his latest pandemic flu update. Sir Liam Donaldson said that in the week to August 27 there were an estimated 5,000 new infections, down from 11,000 the week before.

US to improve monitoring for H1N1
A Presidential advisory group of the US' leading scientists and engineers released a new report assessing the Obama Administration's preparations for this fall's expected resurgence of 2009-H1N1 flu and outlining key steps officials can take in the coming weeks and months to minimize the disease's impact on the nation.

Combined antiviral and chemotherapy to fight HIV AIDS
HIV-AIDS could be treated through a combination of targeted chemotherapy and current Highly Active Retroviral (HAART) treatments, revealed by researchers.

Low cost HIV monitoring test gives result in 30 min
Scientists at the Burnet Institute, Australia's leading medical research and public health institute focused on infectious diseases, have developed a prototype low-cost HIV monitoring test designed for field use in remote settings.

AIDS patients get benefit from early retroviral use
HIV-positive patients who don't seek medical attention until they have a serious AIDS-related condition can reduce their risk of death or other complications by half if they get antiretroviral treatment early on, according to a new multicenter trial led by researchers at the Stanford University School of Medicine.

World is better prepared for influenza pandemic
The world is better prepared for an influenza pandemic than at any time in history, thanks, in part, to vigilance and diligence of countries, Director-General Dr Margaret Chan said in her address to a special meeting of ASEAN+3 health ministers in Bangkok, Thailand.

Swine Flu update for people with heart disease
In general, influenza of all types can pose greater dangers for people with heart failure, or with any cardiovascular disease. Like seasonal flu, swine flu may cause a worsening of underlying chronic medical conditions.

RPSGB warns against counterfeit drugs for swine flu
The Royal Pharmaceutical Society of Great Britain (RPSGB) issued a warning to the public about the risks of buying online medicines for swine influenza, such as Tamiflu or Relenza.

Avoid nonessential travel to Mexico
CDC is concerned that continued travel by U.S. travelers to Mexico presents a serious risk for further outbreaks of swine flu in the United States. At this time, CDC recommends that U.S. travelers avoid all nonessential travel to Mexico.

US declares public health emergency for swine flu
The Department of Health and Human Services of USA issued a nationwide public health emergency declaration in response to recent human infections with a newly discovered swine influenza A (swine flu) virus.

Treating HIV earlier is better
Begin treatment as early as possible: this general common sense rule seems to apply to most diseases except HIV-AIDS, which is only treated once a certain number of immune cells called "CD4+" cells have disappeared.

US AIDS Relief program PEPFAR saved a million lives
PEPFAR, which the Bush administration initially established as a five-year, $15 billion plan, has kept people alive by effectively providing funds for AIDS treatment and care, according to a study from the Stanford University School of Medicine.

New monkey model for HIV
By altering just one gene in HIV-1, scientists have succeeded in infecting pig-tailed macaque monkeys with a human version of the virus that has until now been impossible to study directly in animals.

Evolutionary biologist gets grant to study HIV
Dr. Sara Sawyer will use a $120,000 grant from the Foundation for AIDS Research (amFAR) to study how the HIV virus and the cells it attacks have evolved together over time. The goal of her research is to discover new targets for drugs.

A man defeated HIV virus through bone marrow transplant
An HIV-positive person, who underwent a bone marrow transplant to treat leukemia, has had undetectable HIV viral loads for almost two years. HIV-positive man was ill from leukemia and had underwent treatment by the team led by Prof. Eckhard Thiel, director of the Medical Clinic with a focus on hematology and oncology.

TIM 3 protein turns off HIV fighting T cells
In HIV-infected patients the body's immune system is unable to fight off the virus. A new study to be published online on November 10th in the Journal of Experimental Medicine shows that T cells in HIV-infected individuals express a protein called TIM-3, which inactivates their virus killing capacity.

HIV infected patients should start HAART sooner
Under current treatment guidelines, highly active antiretroviral therapy (HAART) should be considered for HIV-infected patients when their CD4+ T-cell counts fall below 350 cells per cubic millimeter (mm3).

Estimating lives lost due to delay in HIV drug use in South Africa
More than 330,000 lives were lost to HIV/AIDS in South Africa from 2000 and 2005 because a feasible and timely antiretroviral (ARV) treatment program was not implemented, assert researchers from the Harvard School of Public Health (HSPH) in a study published online by the Journal of Acquired Immune Deficiency Syndromes (JAIDS) (http://www.jaids.com/).

Antiretrovirals with TB treatment reduces mortality in HIV patients
A South African treatment study conducted by researchers in the Department of Epidemiology at the Mailman School of Public Health shows that mortality among TB-HIV co-infected patients can be reduced by a remarkable 55%, if antiretroviral therapy (ART) is provided with TB treatment at the same time.

UN hails recipients of Nobel Prize for discovering HIV
The United Nations has applauded the awarding of the 2008 Nobel Prize for Medicine to two French scientists for their discovery of HIV and for their subsequent pioneering research into the virus.

International AIDS Society updates treatment guidelines for HIV infection
An evaluation of recent data has led to an update in the guidelines and recommendations for antiretroviral treatment of adult human immunodeficiency virus (HIV) infection, according to an article in the August 6 issue of JAMA, a theme issue on HIV/AIDS.

Monitoring AIDS treatment by physical signs is effective
When millions of HIV-infected people in poor countries began receiving advanced drug therapies, critics worried that patient care would suffer because few high-tech laboratories were available to guide treatments. But according to a study being published in The Lancet, these concerns are as yet unfounded.

Tenofovir gel safe for daily use
A vag inal microbicide that incorporates an antiretroviral (ARV) drug normally used to treat people with HIV is safe for sexually active HIV-negative women to use every day over an extended period, suggest results of a clinical trial of tenofovir topical gel.

Growth hormone enhances immunity in HIV patients
Growth hormone helps boost the immune system of HIV patients, revealed by researchers. Growth hormone (GH) treatment was associated with increased thymic mass, and increased the number of immune cells HIV patients had circulating in their blood.

GSK reduces HIV drugs prices for poor countries
GSK today announced significant new price reductions for its HIV medicines offered on a not-for-profit basis to the world's poorest countries. This reduction is the fifth time the company has made a price reduction as part of its pioneering preferential pricing policy originally introduced in 1997.

US' 49 states gripped with influenza
After relatively low levels of influenza activity in the early part of the season, since January influenza activity has been picking up in the US. This week 44 states are reporting widespread influenza activity. This is up from 31 states reporting widespread activity last week. Five states are reporting regional activity, making 49 states overall.

HIV persists in gut despite long term HIV therapy
HIV virus is not usually eradicated from infected individuals even after long term HIV therapy because of the persistence of HIV in hideouts known as viral reservoirs. One important reservoir is the gut, where HIV causes much of its damage due to the large number of HIV target cells that reside there.

Breastfeeding safer for infants of HIV mothers with Nevirapine
An antiretroviral drug already in widespread use in the developing world to prevent the transmission of HIV from infected mothers to their newborns during childbirth has also been found to substantially cut the risk of subsequent HIV transmission during breast-feeding.

Study examines effectiveness of antiviral drug to treat mononucleosis
University of Minnesota researchers have begun studying a new drug to treat infectious mononucleosis, commonly known as mono. The goal of the study is to find out if people who take the antiviral drug valomaciclovir recover from mono faster.

European influenza viruses resistant to tamiflu, oseltamivir
Preliminary surveillance into antiviral drug susceptibility against seasonal flu viruses currently circulating in Europe has revealed that some of the A (H1N1) viruses (13%) have shown resistance to the antiviral drug, oseltamivir (Tamiflu). These viruses however, remain sensitive to the antivirals, zanamivir and amantadine.

Intelence, etravirine HIV Drug approved in US
US FDA approved Tibotec Therapeutics' Intelence, etravirine tablets for the treatment of HIV infection, to be used in combination with other anti-HIV medications, in adults who have failed treatment with other antiretrovirals.

AIDS drugs may prevent vaginal transmission of HIV
Prescription drugs now used to treat human immunodeficiency virus infection in adults may prevent the vaginal transmission of HIV, researchers at UT Southwestern Medical Center have found.

Treatment of HIV associated Lipodystrophy Syndrome
Researchers in Montreal and Boston have identified a potential new treatment for the HIV/HAART*-associated Lipodystrophy Syndrome. This syndrome is a common side-effect of anti-retroviral medications to treat HIV infection.

HIV AIDS drug cost trends in Brazil
AIDS continues to be a staggering global public health problem. The World Health Organization estimates that two million people in developing countries (or 25% of those in need in developing countries) receive treatment known as HAART (highly active antiretroviral therapy), more commonly known as "AIDS cocktails."

51 Anti Viral articles listed above.

List health news, Health organizations, Health news world, Glossary, Best health articles, Featured     Go to top

The information provided on Health Newstrack is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. We comply with the HONcode principles for trustworthy health information, and Health News Track is hon code accredited, verify here.
About us, Site map Privacy policy, Disclaimer
© 2007, 2008, 2009, 2010, 2011 HealthNewsTrack.com
2.48